Delivery Order SPE2DB22D3301-SPE2DB23FZ0VB
Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $540
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $16,586 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 18 through 21, 2023. No subcontractors or set aside designations were identified. DLA manages the global supply...
- The Defense Logistics Agency awarded a $1,184 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 22, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued against an unspecified government-wide acquisition...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,173 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by September 15, 2023. As a major provider of medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,172 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is to be performed in Conshohocken, Pennsylvania by Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, and provides 30 units of the ophthalmic solution to support DLA programs. No set-aside designation or subcontractors are indicated. The single day period of performance from September 11-12, 2023...
- The Defense Logistics Agency awarded a $9,085.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561375753 RESTASIS 0.05% eye emulsion bottles. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 30 bottles of the prescribed ophthalmic solution. Performance will take place in Conshohocken, Pennsylvania over a one-day period from June 29, 2023 to June 30, 2023. As a leading provider...
- The Defense Logistics Agency awarded a $540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 30 units of the prescribed ophthalmic solution to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. The order was issued against DLA's prime vendor pharmaceuticals contract...
- The Defense Logistics Agency awarded a $6,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 30 units of the prescribed ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under the start and end dates of September 28 through 29, 2023. The parent company, Amerisourcebergen Corporation, will perform through...
- The Defense Logistics Agency awarded a $2,332.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is September 28 through 29, 2023. As a top pharmaceutical distributor, Amerisourcebergen will fulfill this order to support the DLA's medical supply needs under its Prime Vendor Next contract vehicle. No...
- The Defense Logistics Agency awarded a $7,368.09 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 0.05% RESTASIS eye emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is scheduled to be completed between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for eye medication supports the DLA's mission to provide logistics...
- The Defense Logistics Agency awarded a $4,321 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the product to the DLA under a firm fixed price contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period from July 7-10, 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply chain for...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ0VBDelivery Order
The Defense Logistics Agency awarded a $540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 30 units of the ophthalmic solution to support DLA's medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period in early July 2023. The delivery order was issued under DLA's pharmaceuticals and medical/surgical supply vehicle, with no set aside designation. Amerisourcebergen will utilize its extensive distribution network as the sole performer for this requirement to deliver needed pharmaceutical products for DLA customers.
Generated 12/20/23, 3:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $540 | 7/7/23 |